Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Digital Biomarkers Market Expected To Reach $15.76 Billion By 2030 At 26% CAGR

Digital biomarkers are experiencing significant market expansion, projected to increase from an estimated $4.96 billion in 2025 to $6.26 billion in 2026, reflecting a compound annual growth rate of 26.3%. This upward trajectory during the prior period was fueled by several key factors including the increasing uptake of consumer wearable devices, the proliferation of mobile health applications, a growing incidence of chronic illnesses, the emergence of sophisticated biosensor technology, and a heightened emphasis on proactive health management.

The digital biomarkers market is poised for substantial expansion, with projections indicating a surge to $15.77 billion by 2030, driven by a compound annual growth rate of 26.0%. This notable upswing over the projected timeframe is fueled by several key factors, including greater financial commitment to digital health solutions, escalating consumer desire for individualized health oversight, a broader application of predictive health insights, more seamless integration with electronic health records, and augmented governmental backing for digital biomarker technologies. Significant developments anticipated during this period involve a wider embrace of wearable devices for health tracking, increased reliance on ongoing remote patient monitoring, the growing incorporation of artificial intelligence in health analytics, an expanded use of sensor technology for disease surveillance, and a heightened emphasis on gathering health data instantaneously.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

Digital Biomarkers Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing incidence of long-term health conditions, which are characterized by their slow onset and persistent nature, is anticipated to be a significant driver for the expansion of the digital biomarkers market. These chronic ailments, exacerbated by factors such as aging populations with conditions like osteoarthritis and heart disease, alongside unhealthy dietary habits and sedentary lifestyles, contribute to a heightened risk. Digital biomarkers play a crucial role in managing these chronic diseases by facilitating real-time tracking of health indicators and disease development, thereby allowing for more tailored and prompt medical interventions. To illustrate, data from the Centers for Disease Control and Prevention in April 2025 revealed that in 2023, a substantial 76.4% of American adults, equating to approximately 194 million individuals, reported living with at least one chronic condition. This prevalence was observed at 59.5% in younger adults, rising to 78.4% in middle-aged individuals, and reaching 93.0% among older adults. Consequently, the widespread occurrence of chronic diseases is expected to fuel the growth of the digital biomarker market.

Digital Biomarkers Market Segment Breakdown: Which Categories Generate The Most Revenue?

The digital biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Digital Biomarkers Market Trends Reshaping Industry Growth

Key players within the digital biomarker sector are actively pursuing alliances as a means to broaden their market presence and augment their capabilities. Such strategic alliances involve organizations pooling their assets, knowledge, and endeavors towards shared aims. As an illustration, in September of 2023, ProofPilot, an American firm specializing in clinical trial automation, entered into a strategic pact with Eli Lilly and Company, a US pharmaceutical giant. This collaboration centered on incorporating Lilly’s novel, patent-protected sensor cloud system, Magnol.AI, into ProofPilot’s existing technological framework. Magnol.AI stands out as a sophisticated platform engineered for the secure and efficient handling of voluminous sensor data. The objective of this joint effort is to elevate the conduct of robust digital health studies, thereby expediting early-stage biomedical investigations. Through this integration, investigators gain access to contemporary data science tools and profound understanding derived from sensor readings, synchronizing these insights with outcomes reported by both clinicians and patients to propel advancements in digital health and biomarker discovery.

Digital Biomarkers Market Key Players And Strategic Industry Positioning

Major companies operating in the digital biomarkers market are Pfizer Inc, Bayer AG, F Hoffmann-La Roche Ltd, Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc, Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc, AliveCor Inc, Empatica Inc, ActiGraph LLC, VivoSense Inc, BioSensics LLC, Koneksa Health Inc, ATCOR Medical Pty Ltd, Brainomix Limited

Access The Complete Digital Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Digital Biomarkers Market Regional Analysis And Leading Geography

North Americawas the largest region in the digital biomarkers market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model